Literature DB >> 11968538

[Mantel transplant for defect reconstruction after resection of malignant bone tumors of the lower extremity].

J Hennen1, D Sabo, A K Martini, L Bernd.   

Abstract

We treated 11 patients with primary sarcoma and 1 patient with enchondroma of the femur or tibia. Bridging the osseus defect we used an intercalary allograft shell and contralateral fibula as described by Capanna et al. [7]. The median bone defect after resection of the tumor was 15.7 (9.0-28.5) cm, average follow up was 29.2 (13-56) month. Anastomosis of the autologous fibula was successful in 8 cases. There were 3 cases necessitating later amputation. The other cases showed good clinical (Enneking-score) and radiological (ISOLS-score) results. These results indicate the described technique as a suitable method for defect reconstruction with good functional outcome.

Entities:  

Mesh:

Year:  2002        PMID: 11968538     DOI: 10.1007/s001130100337

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  4 in total

1.  [Bilateral fibula graft. Biological reconstruction following resection of malignant bone tumors].

Authors:  P-U Tunn; T K Moesta; H Delbrück
Journal:  Chirurg       Date:  2006-10       Impact factor: 0.955

2.  [Experiences with vascular pedicled fibula in reconstruction of osseous defects in primary malignant bone tumors].

Authors:  L Bernd; D Sabo; A Zahlten-Hinguranage; P Niemeyer; W Daecke; H G Simank
Journal:  Orthopade       Date:  2003-11       Impact factor: 1.087

3.  Intercalary reconstructions with vascularised fibula and allograft after tumour resection in the lower limb.

Authors:  Katharina Rabitsch; Werner Maurer-Ertl; Ulrike Pirker-Frühauf; Christine Wibmer; Andreas Leithner
Journal:  Sarcoma       Date:  2013-05-23

4.  Bilateral fibular graft: biological reconstruction after resection of primary malignant bone tumors of the lower limb.

Authors:  Maya Niethard; Carmen Tiedke; Dimosthenis Andreou; Frank Traub; Mario Kuhnert; Mathias Werner; Per-Ulf Tunn
Journal:  Sarcoma       Date:  2013-04-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.